why choose us

First received: October 03, 2022

Clinical Trial: Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone

Study Status: Completed

Recruit Status: RECRUITING

Condition: Intracerebral Haemorrhage, Intraventricular

Study Type: INTERVENTIONAL


Official Title: A Non-Randomized Controlled Trial to Examine the Safety and Suitability of Supplementing Early Minimally Invasive Parafascicular Surgery (MIPS) for Clot Evacuation of Basal Ganglia Intracerebral Hemor

Brief Summary: This is an exploratory single-center prospective study of 20 subjects with primary basal ganglia ICH who will receive early MIPS in combination with perioperative pioglitazone treatment.Outcomes will be compared to matched subjects with basal ganglia ICH who undergo MIPS alone as part of the ENRICH trial.This study will take approximately two years to complete.

Read more